Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemotherapy-induced Necrosis in Ewing Sarcoma: Which is the Best Scoring Tool

NCT03968471 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.

NCT NCT03968471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03968471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemotherapy-induced Necrosis in Ewing Sarcoma: Which is the Best Scoring Tool
Lead sponsor
Istituto Ortopedico Rizzoli
Phase
Observational
Overall status
Completed
Start date
May 13, 2019
Completion date
January 15, 2020
Enrollment
474 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma of bone